Related references
Note: Only part of the references are listed.Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
Abdus Samad et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)
Peptide-like and small-molecule inhibitors against Covid-19
Suyash Pant et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Identification of potential molecules against COVID-19 main protease through structure-guided virtual screening approach
Lovika Mittal et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets
Saurabh K. Sinha et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an in silico perspective
Abdo A. Elfiky
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from Western Algeria
Imane Abdelli et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Drug repurposing for coronavirus (COVID-19): in silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes
Ammar D. Elmezayen et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In-silicoapproaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel
Manoj Kumar Gupta et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study
Maryam Enayatkhani et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)
Phulen Sarma et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Computers and viral diseases. Preliminary bioinformatics studies on the design of a synthetic vaccine and a preventative peptidomimetic antagonist against the SARS-CoV-2 (2019-nCoV, COVID-19) coronavirus
B. Robson
COMPUTERS IN BIOLOGY AND MEDICINE (2020)
Evidence for Gastrointestinal Infection of SARS-CoV-2
Fei Xiao et al.
GASTROENTEROLOGY (2020)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China
Fei Yu et al.
MICROBES AND INFECTION (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
First Case of 2019 Novel Coronavirus in the United States
Michelle L. Holshue et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Insights into the Recent 2019 Novel Coronavirus (SARS-CoV-2) in Light of Past Human Coronavirus Outbreaks
Hossam M. Ashour et al.
PATHOGENS (2020)
Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
Jinoos Yazdany et al.
ANNALS OF INTERNAL MEDICINE (2020)
Updated Approaches against SARS-CoV-2
Haiou Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Molecular Dynamics Simulation of Small Molecules Interacting with Biological Membranes
Carlo Martinotti et al.
CHEMPHYSCHEM (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Pathogenesis of COVID-19 from a cell biology perspective
Robert J. Mason
EUROPEAN RESPIRATORY JOURNAL (2020)
Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes
Wei Zhang et al.
EMERGING MICROBES & INFECTIONS (2020)
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
Jasper Fuk-Woo Chan et al.
EMERGING MICROBES & INFECTIONS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Three cases of treatment with nafamostat in elderly patients with COVID-19 pneumonia who need oxygen therapy
Sukbin Jang et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review
James M. Sanders et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 spike-host cell receptor GRP78 binding site prediction
Ibrahim M. Ibrahim et al.
JOURNAL OF INFECTION (2020)
Vaccine designers take first shots at COVID-19
Jon Cohen
SCIENCE (2020)
Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
Barry Rockx et al.
SCIENCE (2020)
The anti-HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV-2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID-19 infections
Farhana Musarrat et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Virology, Epidemiology, Pathogenesis, and Control of COVID-19
Yuefei Jin et al.
VIRUSES-BASEL (2020)
SARS-CoV-2/COVID-19: Viral Genomics, Epidemiology, Vaccines, and Therapeutic Interventions
Mohammed Uddin et al.
VIRUSES-BASEL (2020)
A Review on the Novel Coronavirus Disease based on In-silico Analysis of Various Drugs and Target Proteins
Gauravi N. Trivedi et al.
JOURNAL OF PURE AND APPLIED MICROBIOLOGY (2020)
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease
Donald C. Hall et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France
Matthieu Million et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
Khan Sharun et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2020)
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
Kuldeep Dhama et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases
Cynthia Liu et al.
ACS CENTRAL SCIENCE (2020)
The pandemic pipeline
John Hodgson
NATURE BIOTECHNOLOGY (2020)
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Yadi Zhou et al.
CELL DISCOVERY (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
Qingxian Cai et al.
ENGINEERING (2020)
Remdesivir for the Treatment of Covid-19-Final Report
John H. Beigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Structural basis of SARS-CoV-2 3CL(pro) and anti-COVID-19 drug discovery from medicinal plants
Muhammad Tahir ul Qamar et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Molecular immune pathogenesis and diagnosis of COVID-19
Xiaowei Li et al.
JOURNAL OF PHARMACEUTICAL ANALYSIS (2020)
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient
Emily Hillaker et al.
PHARMACOTHERAPY (2020)
Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro
Ka-Tim Choy et al.
ANTIVIRAL RESEARCH (2020)
Revisiting potential druggable targets againstSARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review
Abdullah Al Mamun Sohag et al.
DRUG DEVELOPMENT RESEARCH (2020)
Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches
Rong Dong et al.
FRONTIERS IN IMMUNOLOGY (2020)
The pathogenesis and treatment of the 'Cytokine Storm' in COVID-19
Qing Ye et al.
JOURNAL OF INFECTION (2020)
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
Pedro M. Folegatti et al.
LANCET (2020)
In silico studies on therapeutic agents for COVID-19: Drug repurposing approach
Bhumi Shah et al.
LIFE SCIENCES (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
An mRNA Vaccine against SARS-CoV-2-Preliminary Report
L. A. Jackson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection
Synat Keam et al.
REVIEWS IN MEDICAL VIROLOGY (2020)
Update on therapeutic approaches and emerging therapies for SARS-CoV-2 virus
Calvin A. Omolo et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2)-an update on the status
Tarek Mohamed Abd El-Aziz et al.
INFECTION GENETICS AND EVOLUTION (2020)
SARS-CoV-2/COVID-19 and advances in developing potential therapeutics and vaccines to counter this emerging pandemic
Ali A. Rabaan et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2020)
Reverse vaccinology assisted designing of multiepitope-based subunit vaccine against SARS-CoV-2
Muhammad Tahir ul Qamar et al.
INFECTIOUS DISEASES OF POVERTY (2020)
Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
Isis Venturi Biembengut et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2020)
The SARS-CoV-2 Vaccine Pipeline: an Overview
Wen-Hsiang Chen et al.
CURRENT TROPICAL MEDICINE REPORTS (2020)
COVID-19: A review of therapeutics under investigation
James C. Crosby et al.
JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN (2020)
A short review on antibody therapy for COVID-19
G. Venkat Kumar et al.
NEW MICROBES AND NEW INFECTIONS (2020)
The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status
Yan-Rong Guo et al.
MILITARY MEDICAL RESEARCH (2020)
Discovering drugs to treat coronavirus disease 2019 (COVID-19)
Liying Dong et al.
DRUG DISCOVERIES AND THERAPEUTICS (2020)
Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19)
Balamurugan Shanmugaraj et al.
ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY (2020)
Potentials of plant-based substance to inhabit and probable cure for the COVID-19
Israt Jahan et al.
TURKISH JOURNAL OF BIOLOGY (2020)
IN Silico Approach of Some Selected Honey Constituents as SARS-CoV-2 Main Protease (COVID-19) Inhibitors
Heba E. Hashem
EURASIAN JOURNAL OF MEDICINE AND ONCOLOGY (2020)
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
Deng-hai Zhang et al.
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2020)
Clinical trials on drug repositioning for COVID-19 treatment
Sandro G. Viveiros Rosa et al.
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH (2020)
Statins and the COVID-19 main protease: in silico evidence on direct interaction
Zeljko Reiner et al.
ARCHIVES OF MEDICAL SCIENCE (2020)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Oseltamivir Treatment of Influenza in Children
Timothy M. Uyeki
CLINICAL INFECTIOUS DISEASES (2018)
Principles of vaccine potency assays
Thorsten Verch et al.
BIOANALYSIS (2018)
On the Integration of In Silico Drug Design Methods for Drug Repurposing
Eric March-Vila et al.
FRONTIERS IN PHARMACOLOGY (2017)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
Lisa Oestereich et al.
ANTIVIRAL RESEARCH (2014)
Big data in biomedicine
Fabricio F. Costa
DRUG DISCOVERY TODAY (2014)
Molecular dynamics simulation of atomic friction: A review and guide
Yalin Dong et al.
JOURNAL OF VACUUM SCIENCE & TECHNOLOGY A (2013)
In silico applications of bioisosterism in contemporary medicinal chemistry practice
George Papadatos et al.
WILEY INTERDISCIPLINARY REVIEWS-COMPUTATIONAL MOLECULAR SCIENCE (2013)
Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus
Chien-Te Tseng et al.
PLOS ONE (2012)
Challenges and advances in computational docking: 2009 in review
Elizabeth Yuriev et al.
JOURNAL OF MOLECULAR RECOGNITION (2011)
A Transmembrane Serine Protease Is Linked to the Severe Acute Respiratory Syndrome Coronavirus Receptor and Activates Virus Entry
Ana Shulla et al.
JOURNAL OF VIROLOGY (2011)
Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro
Yiu-Wing Kam et al.
PLOS ONE (2009)
Informatics and medicine - From molecules to populations
K. A. Kuhn et al.
METHODS OF INFORMATION IN MEDICINE (2008)
Human immunopathogenesis of severe acute respiratory syndrome (SARS)
Mark J. Cameron et al.
VIRUS RESEARCH (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
Analysis of HIV wild-type and mutant structures via in silico docking against diverse ligand libraries
Max W. Chang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2007)
In silico pharmacology for drug discovery: applications to targets and beyond
S. Ekins et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
New insights into the antiviral effects of chloroquine
A Savarino et al.
LANCET INFECTIOUS DISEASES (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome
Y Jiang et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
Immunization with modified vaccinia virus Ankara-based recombinant vaccine against severe acute respiratory syndrome is associated with enhanced hepatitis in ferrets
H Weingartl et al.
JOURNAL OF VIROLOGY (2004)
Predicting ADME properties in silico:: methods and models
D Butina et al.
DRUG DISCOVERY TODAY (2002)
Share Paper
